Three Blood Tests That Actually Matter for Prevention

The wellness industry has turned annual blood work into an anxiety generator. Lists of seven, ten, fourteen markers — each with an “optimal” range that shifts every time a supplement company publishes a blog post. The result is a lot of people worried about their homocysteine while their cardiovascular ceiling is unknown, their metabolic trend is unchecked, and their inflammation level is a total guess.

The Three Tests at a Glance

• ApoB: Counts every plaque-forming particle in your blood — a more accurate cardiovascular risk signal than standard LDL cholesterol alone.
• Fasting Insulin: Reveals insulin resistance years before blood sugar itself rises, catching a metabolic problem at its earliest, most fixable stage.
• hs-CRP: Measures chronic, low-grade inflammation — a modifiable factor that speeds up artery disease independent of your cholesterol levels.

Prevention-focused blood work isn’t a flat list. It has three anchors, and everything else is a distraction until those three are covered. These three markers work like a tripod — each one covers ground no other test touches, and together they answer the three questions that determine whether your prevention plan is actually working.

ApoB is your cardiovascular ceiling. Apolipoprotein B counts every plaque-forming particle in your blood — LDL, VLDL, IDL, and Lp(a) — because each of these particles carries exactly one ApoB molecule ^[1]. LDL-C, the standard measurement, only estimates the mass of cholesterol inside LDL particles. It doesn’t count the particles themselves. It’s the particles that cause plaque, not the cholesterol riding inside them. ApoB tells you how many plaque-forming particles are actually circulating, no matter how much cholesterol each one happens to be carrying.

This distinction matters because two people can have identical LDL-C levels while one has twice as many plaque-forming particles as the other. Someone with many small, dense LDL particles may have “normal” LDL-C (say, 110 mg/dL) but a high ApoB (above 100 mg/dL), and their real risk is higher than someone with the same LDL-C but a low ApoB ^[2]. This mismatch shows up in roughly 15-20% of the population — meaning that many people are being misclassified by the standard cholesterol panel.

Fasting insulin is your metabolic trend. Fasting glucose is a late-stage warning sign — by the time it rises above 100 mg/dL, your pancreas has already been compensating for years, producing extra insulin to make up for reduced sensitivity ^[3]. A fasting glucose of 92 alongside a fasting insulin of 14 µIU/mL isn’t actually “normal.” It’s a pancreas working triple shifts just to keep that number flat. The level worth watching is insulin above 8-10 µIU/mL alongside otherwise normal glucose. The simplest way to quantify it is HOMA-IR: (fasting glucose × fasting insulin) ÷ 405. A result above 2.0 signals insulin resistance. Above 2.5 signals a real metabolic problem, even with perfect fasting glucose.

hs-CRP is your inflammation baseline. High-sensitivity C-reactive protein above 1 mg/L (and especially above 2 mg/L) signals chronic, low-grade inflammation that speeds up artery disease regardless of your cholesterol levels ^[4]. The most common cause of elevated hs-CRP is excess belly fat — fat tissue releases a signal (IL-6) that tells the liver to produce more CRP. But it can also come from a hidden chronic infection (gum disease is a common overlooked culprit), an autoimmune condition, or just an inflammatory diet. hs-CRP is changeable: losing 5-10% of your body weight reliably lowers it, as does regular aerobic exercise, getting enough omega-3s, and cutting out ultra-processed foods. It’s the cheapest, most telling measure of whether your lifestyle is actually working in your favor.

Homocysteine, vitamin D, thyroid panels, lipoprotein(a) — these all matter, but they matter after these three anchors are known. Someone with an ApoB of 90 mg/dL, fasting insulin of 6 µIU/mL, and hs-CRP of 0.6 mg/L has more useful prevention information than someone who’s had all fourteen markers checked but not these three. The extra tests are for fine-tuning after the big questions are answered.

The one exception is Lp(a) — lipoprotein(a) — which should be checked once in your life, because it’s 80-90% determined by your genes and doesn’t respond to lifestyle changes ^[5]. But Lp(a) isn’t a substitute for ApoB — it’s an extra risk factor. Check it once. If it’s high, aim for a lower ApoB target (below 70 mg/dL instead of below 100). If it’s low, you can stop thinking about it.

Bettering Me’s approach: fix the anchors first. Chase the extras only once the anchors are known and stable.

How to actually get these tests. Most standard lab panels don’t include ApoB or fasting insulin by default. You have to ask for them specifically. For ApoB: request “apolipoprotein B” (CPT 82172). For fasting insulin: request “insulin, fasting” (CPT 83525). For hs-CRP: request “C-reactive protein, high sensitivity” (CPT 86141). These three tests add roughly $60-90 to a standard blood draw if insurance doesn’t cover them. Direct-to-consumer labs like Quest and LabCorp offer them as individual add-ons. Several direct-access providers offer prevention-focused panels that already include all three.

How often to retest. ApoB changes slowly — retest every 6-12 months unless you’re on medication for it, in which case retest at 12 weeks after starting. Fasting insulin can shift within 8-12 weeks of a lifestyle change — retest at 12 weeks if you’re making real changes. hs-CRP moves the fastest — it can shift within 4-6 weeks of weight loss, starting an exercise habit, or a diet change. A baseline reading followed by a 12-week follow-up after making changes gives you a clear picture of whether your plan is actually working.

Your homocysteine probably isn’t going to kill you. Your ApoB, fasting insulin, and hs-CRP might — or they might save you, depending on what you do with the information. Fix the anchors first. Then chase the extras.

Disclaimer: This post is for inspiration and education, not medical advice. Everyone’s body is different, so please check with your doctor before changing your diet, exercise, or lifestyle routine. By using these tips, you agree to do so at your own risk.

References

^[1] Sniderman AD, et al. "A meta-analysis of LDL-C, non-HDL-C, and ApoB as markers of cardiovascular risk." *Circ Cardiovasc Qual Outcomes*. 2011;4(3):337-345.. DOI: https://doi.org/10.1161/CIRCOUTCOMES.110.959247

^[2] Otvos JD, et al. "Clinical implications of discordance between LDL-C and particle number." *J Clin Lipidol*. 2011;5(2):105-113.. DOI: https://doi.org/10.1016/j.jacl.2011.02.001

^[3] Kahn SE, Hull RL, Utzschneider KM. "Mechanisms linking obesity to insulin resistance and type 2 diabetes." *Nature*. 2006;444(7121):840-846.. DOI: https://doi.org/10.1038/nature05482

^[4] Ridker PM. "Clinical application of C-reactive protein for cardiovascular disease detection and prevention." *Circulation*. 2003;107(3):363-369.. DOI: https://doi.org/10.1161/01.CIR.0000053730.47739.3C

^[5] Kronenberg F. "Human Genetics and the Causal Role of Lipoprotein(a)." *Cardiovasc Drugs Ther*. 2016;30(1):87-100.. DOI: https://doi.org/10.1007/s10557-016-6648-3

{ “@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [ { “@type”: “Question”, “name”: “Which blood tests matter most for prevention?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “The three blood tests that matter most for prevention are ApoB, fasting insulin, and hs-CRP. ApoB reveals your true cardiovascular particle burden, fasting insulin detects insulin resistance years before glucose rises, and hs-CRP measures chronic inflammation that accelerates heart disease. Together they answer whether your cardiovascular, metabolic, and inflammatory trajectories are under control.” } }, { “@type”: “Question”, “name”: “What blood tests should I get at 40?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “At 40, prioritize ApoB (order CPT 82172), fasting insulin (CPT 83525), and hs-CRP (CPT 86141) — none of which appear on most standard panels by default. These three markers give you a cardiovascular ceiling, a metabolic trajectory, and an inflammatory baseline. They add roughly 0–90 out-of-pocket and provide far more actionable prevention information than the typical lipid panel alone.” } }, { “@type”: “Question”, “name”: “Why are standard cholesterol panels not enough for prevention?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “Standard LDL-C panels estimate the mass of cholesterol inside particles but do not count the particles themselves — and it is the particles that cause plaque. Two people can have identical LDL-C while one has twice as many atherogenic particles. This discordance occurs in roughly 15–20% of the population, leaving them misclassified as low risk when ApoB would flag elevated particle counts. Adding fasting insulin and hs-CRP fills the metabolic and inflammatory gaps the lipid panel ignores entirely.” } } ] }